메뉴 건너뛰기




Volumn 50, Issue 2, 2002, Pages 253-258

Cost effectiveness of combination therapy for hepatitis C: A decision analytic model

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

EID: 0036153381     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.2.253     Document Type: Article
Times cited : (58)

References (37)
  • 4
    • 0033929974 scopus 로고    scopus 로고
    • Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: Uptake and acceptability of named antenatal testing
    • (2000) Gut , vol.47 , pp. 277-280
    • Ward, C.1    Tudor-Williams, G.2    Cotzias, T.3
  • 10
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    • International Hepatitis Interventional Therapy Group [IHIT)
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.S.3
  • 16
    • 0029084933 scopus 로고
    • Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C
    • (1995) Hepatology , vol.22 , pp. 1050-1056
    • Martinot-Peignoux, M.1    Marcellin, P.2    Pouteau, M.3
  • 26
    • 0028103861 scopus 로고
    • Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: Results of a randomized, multicenter clinical trial
    • (1994) Hepatology , vol.20 , pp. 618-625
  • 33


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.